OBJECTIVES: The response of anthrax lethal toxin (LeTx) induced shock and lethality to conventional therapies has received little study. Previously, fluids worsened outcome in LeTx-challenged rats in contrast to its benefit with lipopolysaccharide (LPS) or Escherichia coli. The current study investigated norepinephrine treatment. MEASUREMENTS AND MAIN RESULTS: Sprague-Dawley rats (n = 232) weighing between 230 and 250 g were challenged with similar lethal (80%) 24-hour infusions of either LPS or LeTx, or with diluent only. Toxin-challenged animals were also randomized to receive 24-hour infusions with one of three doses of norepinephrine (0.03, 0.3, or 3.0 microg/kg/min) or placebo started 1 hour after initiation of challenge. All toxin animals received similar volumes of fluid over the 24 hours (equivalent to 4.0-4.3 mL/kg/hr). Although the intermediate norepinephrine dose (0.3 microg/kg/min for 24 hours) improved survival with LPS (p = 0.04) and increased blood pressure before the onset of lethality with LeTx (p < 0.0001), it did not improve survival with the latter (p = ns). Furthermore, neither increasing nor decreasing norepinephrine doses improved survival with LeTx. CONCLUSION: Hypotension with LeTx may not be a primary cause of lethality in this model. Rather, LeTx may cause direct cellular injury insensitive to vasopressors. These findings suggest that during anthrax infection and shock, along with hemodynamic support, toxin-directed treatments may be necessary as well.
OBJECTIVES: The response of anthrax lethal toxin (LeTx) induced shock and lethality to conventional therapies has received little study. Previously, fluids worsened outcome in LeTx-challenged rats in contrast to its benefit with lipopolysaccharide (LPS) or Escherichia coli. The current study investigated norepinephrine treatment. MEASUREMENTS AND MAIN RESULTS:Sprague-Dawley rats (n = 232) weighing between 230 and 250 g were challenged with similar lethal (80%) 24-hour infusions of either LPS or LeTx, or with diluent only. Toxin-challenged animals were also randomized to receive 24-hour infusions with one of three doses of norepinephrine (0.03, 0.3, or 3.0 microg/kg/min) or placebo started 1 hour after initiation of challenge. All toxin animals received similar volumes of fluid over the 24 hours (equivalent to 4.0-4.3 mL/kg/hr). Although the intermediate norepinephrine dose (0.3 microg/kg/min for 24 hours) improved survival with LPS (p = 0.04) and increased blood pressure before the onset of lethality with LeTx (p < 0.0001), it did not improve survival with the latter (p = ns). Furthermore, neither increasing nor decreasing norepinephrine doses improved survival with LeTx. CONCLUSION:Hypotension with LeTx may not be a primary cause of lethality in this model. Rather, LeTx may cause direct cellular injury insensitive to vasopressors. These findings suggest that during anthraxinfection and shock, along with hemodynamic support, toxin-directed treatments may be necessary as well.
Authors: Glenn Hernandez; Alejandro Bruhn; Carlos Romero; Francisco Javier Larrondo; Rene De La Fuente; Luis Castillo; Guillermo Bugedo Journal: Resuscitation Date: 2005-07 Impact factor: 5.262
Authors: Aaron M Firoved; Georgina F Miller; Mahtab Moayeri; Rahul Kakkar; Yuequan Shen; Jason F Wiggins; Elizabeth M McNally; Wei-Jen Tang; Stephen H Leppla Journal: Am J Pathol Date: 2005-11 Impact factor: 4.307
Authors: G Mani Subramanian; Patrick W Cronin; Gerald Poley; Andrea Weinstein; Susan M Stoughton; John Zhong; Ying Ou; Jonathan F Zmuda; Blaire L Osborn; William W Freimuth Journal: Clin Infect Dis Date: 2005-05-24 Impact factor: 9.079
Authors: Xizhong Cui; Yan Li; Mahtab Moayeri; Gil H Choi; G M Subramanian; Xuemei Li; Michael Haley; Yvonne Fitz; Jing Feng; Steven M Banks; Stephen H Leppla; Peter Q Eichacker Journal: J Infect Dis Date: 2004-12-22 Impact factor: 5.226
Authors: Daniel A Sweeney; Caitlin W Hicks; Xizhong Cui; Yan Li; Peter Q Eichacker Journal: Am J Respir Crit Care Med Date: 2011-08-18 Impact factor: 21.405
Authors: Amisha V Barochia; Xizhong Cui; Junfeng Sun; Yan Li; Steven B Solomon; Thi-Sau Migone; G Mani Subramanian; Sally D Bolmer; Peter Q Eichacker Journal: J Infect Dis Date: 2012-01-05 Impact factor: 5.226
Authors: Daniel A Sweeney; Xizhong Cui; Steven B Solomon; David A Vitberg; Thi S Migone; Dara Scher; Robert L Danner; Charles Natanson; G Mani Subramanian; Peter Q Eichacker Journal: J Infect Dis Date: 2010-11-10 Impact factor: 5.226